首页> 美国卫生研究院文献>Scientific Reports >Defining the genes for the final steps in biosynthesis of the complex polyketide antibiotic mupirocin by Pseudomonas fluorescens NCIMB10586
【2h】

Defining the genes for the final steps in biosynthesis of the complex polyketide antibiotic mupirocin by Pseudomonas fluorescens NCIMB10586

机译:荧光假单胞菌NCIMB10586定义复杂聚酮化合物抗生素莫匹罗星生物合成最后步骤的基因

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The mupirocin trans-AT polyketide synthase pathway, provides a model system for manipulation of antibiotic biosynthesis. Its final phase involves removal of the tertiary hydroxyl group from pseudomonic acid B, PA-B, producing the fully active PA-A in a complex series of steps. To further clarify requirements for this conversion, we fed extracts containing PA-B to mutants of the producer strain singly deficient in each mup gene. This additionally identified mupM and mupN as required plus the sequence but not enzymic activity of mupL and ruled out need for other mup genes. A plasmid expressing mupLMNOPVCFU + macpE together with a derivative of the producer P. fluorescens strain NCIMB10586 lacking the mup cluster allowed conversion of PA-B to PA-A. MupN converts apo-mAcpE to holo-form while MupM is a mupirocin-resistant isoleucyl tRNA synthase, preventing self-poisoning. Surprisingly, the expression plasmid failed to allow the closely related P. fluorescens strain SBW25 to convert PA-B to PA-A.
机译:莫匹罗星反式-AT聚酮合酶途径,提供了一个模型系统来操纵抗生素的生物合成。其最后阶段涉及从假单酸B PA-B中除去叔羟基,从而通过一系列复杂的步骤生产出具有完全活性的PA-A。为了进一步阐明这种转化的要求,我们将含有PA-B的提取物喂食了每个mup基因中唯一缺失的生产菌株的突变体。这还确定了所需的mupM和mupN以及序列,但未鉴定mupL的酶活性,并排除了对其他mup基因的需求。表达mupLMNOPVCFU ++ macpE的质粒与缺乏mup簇的生产性荧光假单胞菌菌株NCIMB10586的衍生物一起使PA-B转化为PA-A。 MupN将apo-mAcpE转化为完整形式,而MupM是耐Mupirocin的异亮氨酰tRNA合酶,可防止自身中毒。令人惊讶地,表达质粒不能使紧密相关的荧光假单胞菌菌株SBW25将PA-B转化成PA-A。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号